Radiopharm Theranostics Ltd (RADX) Intangibles (2023 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Intangibles of $46.6 million for Q2 2025, down 5.12% year-over-year from $49.1 million in Q2 2024, and down 5.12% quarter-over-quarter from $49.1 million in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Intangibles (2023 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Intangibles for 3 consecutive years, with $46.6 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Intangibles fell 5.12% year-over-year to $46.6 million; the TTM figure through Jun 2025 stood at $46.6 million (down 5.12% YoY), while the FY2025 annual figure was $46.6 million, down 5.12% from the prior year.
- Intangibles eased to $46.6 million in Q2 2025 per RADX's latest filing, from $49.1 million in the prior quarter.
- Across five years, Intangibles topped out at $58.5 million in Q2 2023 and bottomed at $46.6 million in Q2 2025.
- Historically, Intangibles has averaged $51.4 million across 3 years, with a median of $49.1 million in 2024.
- Annual changes were most pronounced in 2024 — Intangibles retreated 16.15% — and 2025, when it dropped 5.12%.
- Radiopharm Theranostics' Intangibles stood at $58.5 million in 2023, then fell by 16.15% to $49.1 million in 2024, then decreased by 5.12% to $46.6 million in 2025.
- Business Quant data shows RADX's Intangibles at $46.6 million in Q2 2025, $49.1 million in Q2 2024, and $58.5 million in Q2 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 46.57 Mn |
| Jun 30, 2024 | 49.09 Mn |
| Jun 30, 2023 | 58.54 Mn |